Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...

If Medicaid is taken away, children could still receive vaccination coverage through a variety of other programs, including the Children's Health Insurance Program or the Title V Maternal and Child ...

But that effort hasn't come without costs. In 2024’s fourth quarter, Moderna’s cost of sales came ... home $3.2 billion in revenue, down around 72% from the $6.8 billion it generated in ...

justifying a "hold" position rather than a "sell.". Moderna (NASDAQ:MRNA), which went public at $22 in 2018, didn't deviate from this level until 2020. But in 2020, when it became clear that COVID ...

Solano County issued a countywide Shelter at Home Health Order and Directive to continue protecting the health and safety of ...

CrowdStrike stock falls after the cybersecurity company issues a fiscal 2026 outlook well below analysts’ expectations, ...

Bird flu isn’t ... Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 hours ...

Charles River Labs in recent years has bought a 90% controlling interest in Noveprim, a non-human primates supplier in Mauritius, for roughly $234.6 million, plus up to $72 million in deferred and ...

It's been nearly five years since the first case of COVID-19 was reported in Kentucky. Since that day, researchers at the ...

"We are currently engaging with market participants," a spokesperson for South Africa's Competition Commission told Reuters, declining to provide details. USAID cuts put tuberculosis response in peril ...

Toromont Industries Ltd. (T.TIH) (Q4) EPS of $1.72, compared to $1.59 in the prior-year quarter ... compared to $1.06 in the prior-year quarter. Moderna (NASDAQ: MRNA) (Q4) EPS for loss of $2.86, ...